title: Canadian Clinical Practice Guidelines for Rosacea.
abstract: Rosacea is a chronic facial inflammatory dermatosis characterized by background facial erythema and flushing and may be accompanied by inflammatory papules and pustules, cutaneous fibrosis and hyperplasia known as phyma, and ocular involvement. These features can have adverse impact on quality of life, and ocular involvement can lead to visual dysfunction. The past decade has witnessed increased research into pathogenic pathways involved in rosacea and the introduction of novel treatment innovations. The objective of these guidelines is to offer evidence-based recommendations to assist Canadian health care providers in the diagnosis and management of rosacea. These guidelines were developed by an expert panel of Canadian dermatologists taking into consideration the balance of desirable and undesirable outcomes, the quality of supporting evidence, the values and preferences of patients, and the costs of treatment. The 2015 Cochrane review "Interventions in Rosacea" was used as a source of clinical trial evidence on which to base the recommendations.
authors.affiliation: Division of Dermatology, Queen's University, Kingston, ON, Canada.
authors.forename: Yuka
authors.initials: Y
authors.lastname: Asai
authors.affiliation: University of Western Ontario, Windsor, ON, Canada jerrytan@bellnet.ca.
authors.forename: Jerry
authors.initials: J
authors.lastname: Tan
authors.affiliation: University of Toronto, Toronto, ON, Canada.
authors.forename: Akerke
authors.initials: A
authors.lastname: Baibergenova
authors.affiliation: Toronto Dermatology Centre, Toronto, ON, Canada.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Barankin
authors.affiliation: Bearing Biomedical Consulting, Vancouver, BC, Canada.
authors.forename: Chris L
authors.initials: CL
authors.lastname: Cochrane
authors.affiliation: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
authors.forename: Shannon
authors.initials: S
authors.lastname: Humphrey
authors.affiliation: University of Toronto, Toronto, ON, Canada.
authors.forename: Charles W
authors.initials: CW
authors.lastname: Lynde
authors.affiliation: CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada.
authors.forename: Danielle
authors.initials: D
authors.lastname: Marcoux
authors.affiliation: Laval University, Quebec City, QC, Canada.
authors.forename: Yves
authors.initials: Y
authors.lastname: Poulin
authors.affiliation: Bearing Biomedical Consulting, Vancouver, BC, Canada Pacific DermAesthetics, Vancouver, BC, Canada.
authors.forename: Jason K
authors.initials: JK
authors.lastname: Rivers
authors.affiliation: Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
authors.forename: Mariusz
authors.initials: M
authors.lastname: Sapijaszko
authors.affiliation: University of Toronto, Toronto, ON, Canada.
authors.forename: R Gary
authors.initials: RG
authors.lastname: Sibbald
authors.affiliation: University of Manitoba, Winnipeg, MB, Canada.
authors.forename: John
authors.initials: J
authors.lastname: Toole
authors.affiliation: Bearing Biomedical Consulting, Vancouver, BC, Canada Carruthers & Humphrey, Vancouver, BC, Canada.
authors.forename: Marcie
authors.initials: M
authors.lastname: Ulmer
authors.affiliation: University of Calgary, Calgary, AB, Canada.
authors.forename: Catherine
authors.initials: C
authors.lastname: Zip
mesh_terms: D006801:Humans; D000890:Anti-Infective Agents / Q000627:therapeutic use; D032921:Consensus; D003879:Dermatologic Agents / Q000627:therapeutic use; D003998:Dicarboxylic Acids / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology; D062325:Intense Pulsed Light Therapy; D015474:Isotretinoin / Q000627:therapeutic use; D007559:Ivermectin / Q000627:therapeutic use; D053685:Laser Therapy; D008795:Metronidazole / Q000627:therapeutic use; D016311:Outliers, DRG; D012393:Rosacea / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D013752:Tetracycline / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; C010038:azelaic acid; D003879:Dermatologic Agents; D003998:Dicarboxylic Acids; D004318:Doxycycline; D015474:Isotretinoin; D007559:Ivermectin; D008795:Metronidazole; D013752:Tetracycline
keywords: dermatology; inflammatory dermatoses; laser; rosacea